Indication
Short bowel syndrome
Short bowel syndrome is a complex malabsorptive condition characterized by intestinal failure resulting from the extensive surgical resection, congenital absence, or severe disease-associated loss of functional small intestine. Read more about Short bowel syndrome
12 drugs 8 manufacturers
Drugs that treat it
Common Short bowel syndrome therapies.
ZORBTIVE (somatropin)
GATTEX (teduglutide)
GATTEX (teduglutide)
GLUTASOLVE (glutamine)
GATTEX (teduglutide)
GATTEX (teduglutide)
ENDARI (glutamine)
GATTEX ONE-VIAL (teduglutide)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonShort bowel syndrome is a complex malabsorptive condition characterized by intestinal failure resulting from the extensive surgical resection, congenital absence, or severe disease-associated loss of functional small intestine.
Affecting pediatric and adult populations, the hallmark pathophysiology is a critically reduced mucosal absorptive surface area, typically defined in adults as having less than 200 centimeters of functional small bowel in continuity.
This anatomical loss compromises the gastrointestinal system’s ability to absorb macronutrients, micronutrients, water, and electrolytes.
Patients clinically present with chronic secretory diarrhea, steatorrhea, dehydration, significant weight loss, progressive malnutrition, and a frequent dependence on supplemental enteral or parenteral nutrition.
- nih.gov
Short bowel syndrome is a complex malabsorptive condition characterized by intestinal failure resulting from the extensive surgical resection, congenital absence, or severe disease-associated loss of functional small intestine
- nih.gov
Short bowel syndrome is a complex malabsorptive condition characterized by intestinal failure resulting from the extensive surgical resection, congenital absence, or severe disease-associated loss of functional small intestine Affecting pediatric and adult populations, the hallmark pathophysiology is a critically reduced mucosal absorptive surface area, typically defined in adults as having less than 200 centimeters of functional small bowel in continuity This anatomical loss compromises the gas...
- mayoclinic.org
Short bowel syndrome is a complex malabsorptive condition characterized by intestinal failure resulting from the extensive surgical resection, congenital absence, or severe disease-associated loss of functional small intestine This anatomical loss compromises the gastrointestinal system’s ability to absorb macronutrients, micronutrients, water, and electrolytes Patients clinically present with chronic secretory diarrhea, steatorrhea, dehydration, significant weight loss, progressive malnutrition...
- nih.gov
Affecting pediatric and adult populations, the hallmark pathophysiology is a critically reduced mucosal absorptive surface area, typically defined in adults as having less than 200 centimeters of functional small bowel in continuity
Personalize your experience
Follow Short bowel syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.